School of Medicine and Biomedical Sciences

Research and Facilities

Our research enterprise encompasses a broad array of basic, translational and clinical outcomes studies. Scientists self-associate with focus groups to investigate human disease and are supported by cutting-edge technologies and core instrumentation facilities.

Researcher Spotlight

10/25/12

Our faculty’s expertise spans essentially all fields of modern biomedical sciences. Many have a track record of accomplishments that has won them international recognition as leaders in their fields.

Collaborative Research Efforts

4/11/13

UB is investing in eight areas of strategic strength identified in our long-range plan. Each established area of research involves multidisciplinary collaboration among faculty members and has a global impact.

Recent Faculty Publications

3/25/13

View a listing of our faculty’s most recent publications.

Research Centers

10/25/12

Collaborative, multidisciplinary research is strongly encouraged and takes place in a broad spectrum of well-established centers across the university.

Core Facilities

10/25/12

Our school’s shared core instrumentation and transgenic animal facilities support research by UB faculty and investigators at our affiliated institutions.

Researcher Spotlight

Molecular Parasitology

10/25/12

Noreen Williams, PhD, studies parasitic protozoans, including Trypanosoma brucei, which causes African sleeping sickness, transmitted by the tse-tse fly; and Trypanosoma cruzi, which causes Chagas’ disease, transmitted by the reduviid bug.
Copper and Iron Transport

10/25/12

Daniel Kosman, PhD, studies how organisms acquire and metabolize iron and copper, intrinsically toxic metals essential to cellular respiration and oxygen transport. One of his goals is to develop antifungal drugs to treat infections in humans.
Addiction: Rewiring the Brain

10/25/12

David Dietz, PhD, investigates cellular changes by which drugs “hijack” the central nervous system’s reward circuitry, causing addiction. He studies how differences in individuals’ molecular and behavioral plasticity mediate susceptibility to drug abuse and relapse.
Brain Function and Disease

10/25/12

Gabriela Popescu, PhD, is studying NMDA receptors in the brain, which are involved in synaptic development, plasticity, memory and learning, as well as in pathologies such as stroke, neurodegeneration, chronic pain, addiction, schizophrenia and epilepsy.
The Genomics of Myelination

10/25/12

Fraser J. Sim, PhD, studies the molecular mechanisms controlling stem and progenitor cell fate in the human brain. His lab seeks to develop novel drug- and cell-based therapies for repair and regeneration in demyelinating diseases, such as multiple sclerosis.
Bacterial Pathogenesis

10/25/12

Thomas Russo, MD, is internationally known for his work with strains of E. coli that cause infections outside the intestine and result in morbidity worldwide due to pneumonia, urinary tract infections and meningitis.